Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption.
We investigated whether therapeutic vaccination in highly active antiretroviral therapy (HAART)-treated patients with a modified vaccinia virus Ankara-vectored HIV-1 vaccine, with or without therapy interruption, induced the production of interleukin (IL)-10. Plasma IL-10 levels were not significant...
প্রধান লেখক: | Yang, H, Guimarães-Walker, A, Hibbs, S, Dong, T, Stacey, A, Borrow, P, Hanke, T, Davenport, M, McMichael, A, Dorrell, L |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
2009
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
অনুযায়ী: Touloumi, G, অন্যান্য
প্রকাশিত: (2006) -
TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
অনুযায়ী: Angus, B, অন্যান্য
প্রকাশিত: (2008) -
Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.
অনুযায়ী: Dorrell, L, অন্যান্য
প্রকাশিত: (2005) -
Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
অনুযায়ী: Mocroft, A, অন্যান্য
প্রকাশিত: (2009) -
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
অনুযায়ী: Gondim, MVP, অন্যান্য
প্রকাশিত: (2021)